Bower Raises $2M for AI Research OS Platform

In a move set to redefine scientific discovery, Australian startup Bower has successfully closed a $2 million pre-Seed funding round. This capital injection will fuel the development of its innovative AI-powered platform designed to capture and structure experimental data directly from the lab environment. The round was spearheaded by prominent venture capital firm TEN13, with significant participation from Admiralty Capital Group and Edale Capital. A notable group of angel investors, including Heidi Health CTO Yu Liu, Dean Kelly, Harry Uffindell, and Emma Ferrier, also contributed, alongside strategic advisor Bernhard Hans Weigl.

Bower aims to bridge the critical gap between raw experimental observation and actionable scientific knowledge. The company is developing a unique system that integrates with wearable technology, essentially creating an "operating system for research." This system will meticulously record scientists' visual inputs, verbal communications, and actions during experiments, capturing nuances and insights often lost in traditional documentation methods. This approach, termed 'augmented research' by CEO and co-founder Michelle MacRae, addresses the pervasive issue of knowledge attrition that occurs between the laboratory bench, physical notebooks, and a researcher's memory.

The potential impact of Bower's technology is substantial, particularly within the rapidly advancing fields of life sciences and materials science, where the meticulous recording of experimental parameters is paramount. The global AI in scientific research market is projected for significant expansion, driven by the need for accelerated discovery and the increasing complexity of research projects. By automating the administrative burden and ensuring comprehensive data capture, Bower allows researchers to dedicate more time to core scientific inquiry, potentially speeding up the pace of innovation across various disciplines.

Michelle MacRae, a former leader in generative AI video at Microsoft and experienced AI product professional from Dovetail and Google, co-founded Bower with Chief Science Officer Renaud Joannes-Boyau, a professor of geochemistry. The core team also includes CTO David Lyon, an ex-engineer from Atlassian and Xero, and CRO James Boysons, a co-founder of the commerce platform EQL. This blend of AI expertise, scientific acumen, and operational experience positions Bower to effectively tackle the challenges of integrating advanced technology into rigorous scientific workflows.

Professor Joannes-Boyau emphasized the transformative potential, stating, "If you improve how scientific knowledge is captured and structured at the moment it’s created, you don’t just save time, you change the rate at which science progresses." Early adopters of Bower's technology include esteemed institutions such as Mount Sinai Hospital in New York, Mass Affinity, Bloodless Diagnostics, and Southern Cross University, underscoring the immediate relevance and demand for such a solution.

Stew Glynn, Managing Partner at TEN13, highlighted the strategic importance of Bower's focus. "LLMs have gotten very good at reasoning about science and breaking down complex problems," Glynn noted. "What they still can’t do is see what happened in the lab. Most of that work never gets written down, so it never reaches the next researcher, the next model, or the paper. Bower fixes the input problem, and that’s the constraint everyone else is building on top of." The newly acquired funds will be allocated to refining the Bower platform and establishing partnerships for PPE-certified wearables over the next six months, paving the way for broader product rollout.